Cite
MLA Citation
S Danese et al.. “DOP72 Safety, tolerability and efficacy of anti-TL1A antibody PF-06480605 in treatment of ulcerative colitis: The open-label, multicentre, Phase 2a TUSCANY study.” Journal of Crohn's and colitis, vol. 14, n.d., pp. S108–S110. http://access.bl.uk/ark:/81055/vdc_100099171458.0x000034